Literature DB >> 15212945

Neuronal differentiation of embryonic midbrain cells by upregulation of peroxisome proliferator-activated receptor-gamma via the JNK-dependent pathway.

Ki Sook Park1, Rhee Da Lee, Sun-Kyung Kang, Soon Young Han, Kui Lae Park, Ki Hwa Yang, Youn Sook Song, Hye Ji Park, Yoot Mo Lee, Yeo Pyo Yun, Ki Wan Oh, Dae Joong Kim, Young Won Yun, Se Jin Hwang, Sung Eun Lee, Jin Tae Hong.   

Abstract

Our previous study showed that the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) agonist 15-deoxy-PGJ(2) has the promoting ability to differentiate neuronal PC12 cells. To expand our study, the effect of 15-deoxy-PGJ(2) on the differentiation of embryonic midbrain cells into dopaminergic neuronal cells was investigated in this study. The relationship between cell differentiation with activation of PPAR-gamma and the possible signal pathway were also investigated. 15-Deoxy-PGJ(2) increased neurite extension, a typical characteristic of the differentiation of embryonic midbrain cells isolated from 12-day rat embryos in a dose-dependent manner. The expression of differentiation markers, neurofilament, tyrosine hydroxylase, and nestin, was also increased by the treatment of 15-deoxy-PGJ(2). Consistent with the increasing effect on cell differentiation, 15-deoxy-PGJ(2) increased the expression and transcriptional activity of PPAR-gamma in cultured embryonic midbrain cells. In addition, the expression of PPAR-gamma and NeuN in the differentiated neuron of fetus (17 days) and adult rat brain was co-localized. Furthermore, treatment of PPAR-gamma antagonist bisphenol A diglycidyl ether blocked 15-deoxy-PGJ(2)-induced neuronal differentiation of embryonic midbrain cells and expression of PPAR-gamma. To elucidate the possible signal pathway, the activation of mitogenic-activated protein (MAP) kinase family was determined. 15-Deoxy-PGJ(2) (0.5 microM) increased activation of Jun N-terminal kinase (JNK) and p38 kinase but not extra-signal response kinase (ERK). In addition, NGF (50 ng/ml) further increased the 15-deoxy-PGJ(2)-induced JNK activation. Moreover, pretreatment of specific inhibitor of JNK SP600125 blocked the 15-deoxy-PGJ(2)-induced JNK activation. This inhibition correlated well with the inhibition of neurite extension and expression of PPAR-gamma induced by 15-deoxy-PGJ(2). The present results therefore indicate that 15-deoxy-PGJ(2) stimulates differentiation of embryonic midbrain cells into dopaminergic neuronal cells, and its effect may be PPAR-gamma and JNK signal pathway dependent.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15212945     DOI: 10.1016/j.yexcr.2004.03.034

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  46 in total

1.  Proteinase-activated receptor-1 and -2 induce the release of chemokine GRO/CINC-1 from rat astrocytes via differential activation of JNK isoforms, evoking multiple protective pathways in brain.

Authors:  Yingfei Wang; Weibo Luo; Georg Reiser
Journal:  Biochem J       Date:  2007-01-01       Impact factor: 3.857

Review 2.  Metabolic reprogramming in dietary restriction.

Authors:  Rozalyn M Anderson; Richard Weindruch
Journal:  Interdiscip Top Gerontol       Date:  2007

Review 3.  Nuclear receptor regulation of stemness and stem cell differentiation.

Authors:  Yangsik Jeong; David J Mangelsdorf
Journal:  Exp Mol Med       Date:  2009-08-31       Impact factor: 8.718

Review 4.  Nuclear receptors in neural stem/progenitor cell homeostasis.

Authors:  Dimitrios Gkikas; Matina Tsampoula; Panagiotis K Politis
Journal:  Cell Mol Life Sci       Date:  2017-06-21       Impact factor: 9.261

5.  Secretome Cues Modulate the Neurogenic Potential of Bone Marrow and Dental Stem Cells.

Authors:  Ajay Kumar; Vinod Kumar; Vidya Rattan; Vivekanand Jha; Shalmoli Bhattacharyya
Journal:  Mol Neurobiol       Date:  2016-07-15       Impact factor: 5.590

6.  Constitutively active cytoplasmic c-Jun N-terminal kinase 1 is a dominant regulator of dendritic architecture: role of microtubule-associated protein 2 as an effector.

Authors:  Benny Björkblom; Nina Ostman; Vesa Hongisto; Vladislav Komarovski; Jan-Jonas Filén; Tuula A Nyman; Tuula Kallunki; Michael J Courtney; Eleanor T Coffey
Journal:  J Neurosci       Date:  2005-07-06       Impact factor: 6.167

Review 7.  Peroxisome proliferator-activated receptor γ (PPARγ): A master gatekeeper in CNS injury and repair.

Authors:  Wei Cai; Tuo Yang; Huan Liu; Lijuan Han; Kai Zhang; Xiaoming Hu; Xuejing Zhang; Ke-Jie Yin; Yanqin Gao; Michael V L Bennett; Rehana K Leak; Jun Chen
Journal:  Prog Neurobiol       Date:  2017-10-12       Impact factor: 11.685

Review 8.  Thermodynamics in Neurodegenerative Diseases: Interplay Between Canonical WNT/Beta-Catenin Pathway-PPAR Gamma, Energy Metabolism and Circadian Rhythms.

Authors:  Alexandre Vallée; Yves Lecarpentier; Rémy Guillevin; Jean-Noël Vallée
Journal:  Neuromolecular Med       Date:  2018-03-23       Impact factor: 3.843

Review 9.  Interactions Between the Canonical WNT/Beta-Catenin Pathway and PPAR Gamma on Neuroinflammation, Demyelination, and Remyelination in Multiple Sclerosis.

Authors:  Alexandre Vallée; Jean-Noël Vallée; Rémy Guillevin; Yves Lecarpentier
Journal:  Cell Mol Neurobiol       Date:  2017-09-13       Impact factor: 5.046

10.  Neuronal peroxisome proliferator-activated receptor gamma signaling: regulation by mood-stabilizer valproate.

Authors:  Martin J Lan; Peixiong Yuan; Guang Chen; Husseini K Manji
Journal:  J Mol Neurosci       Date:  2008-04-25       Impact factor: 3.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.